Corrigendum: A knockin mouse model of spinocerebellar ataxia type 3 exhibits prominent aggregate pathology and aberrant splicing of the disease gene transcript [Human Molecular Genetics, 24, (2015) (1211-1224)] doi: 10.1093/hmg/ddu532;A knockin mouse model of spinocerebellar ataxia type 3 exhibits prominent aggregate pathology and aberrant splicing of the disease gene transcript

Human Molecular Genetics

Volumn 24, Issue 5, 2015, Pages 1211-1224

  Ramani, Biswarathan ^a   Harris, Ginny M ^b,d   Huang, Rogerio ^a   Seki, Takahiro ^a   Murphy, Geoffrey G ^a   Do Carmo Costa, Maria ^a   Fischer, Svetlana ^a   Saunders, Thomas L ^a   Xia, Guangbin ^c   McEachin, Richard C ^a   Paulson, Henry L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 3; POLYGLUTAMINE; UBIQUITIN; ATXN3 PROTEIN, HUMAN; ATXN3 PROTEIN, MOUSE; MUTANT PROTEIN; NERVE PROTEIN; NUCLEAR PROTEIN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

ALTERNATIVE RNA SPLICING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CAG REPEAT; CELL NUCLEUS INCLUSION BODY; CEREBELLAR ATAXIA; CEREBELLUM NUCLEUS; CONTROLLED STUDY; ELECTROPHORESIS; EXON; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HOMOLOGOUS RECOMBINATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPINOCEREBELLAR ATAXIA TYPE 3; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL LINE; DISEASE MODEL; FEMALE; FIBROBLAST; GENE LOCUS; GENETICS; HUMAN; MACHADO JOSEPH DISEASE; MALE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; UPREGULATION;

MURINAE; MUS;

ALTERNATIVE SPLICING; ANIMALS; ATAXIN-3; BASE SEQUENCE; CELL LINE; DISEASE MODELS, ANIMAL; EXONS; FEMALE; FIBROBLASTS; GENE KNOCK-IN TECHNIQUES; GENETIC LOCI; HUMANS; MACHADO-JOSEPH DISEASE; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84924488574     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddx176     Document Type: Erratum

References (69)

1. Todd, T.W. and Lim, J. (2013) Aggregation formation in the polyglutamine diseases: protection at a cost? Mol. Cells, 36, 185-194.
2. Burnett, B., Li, F. and Pittman, R.N. (2003) The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum. Mol. Genet., 12, 3195-3205.
3. Paulson, H.L., Perez, M.K., Trottier, Y., Trojanowski, J.Q., Subramony, S.H., Das, S.S., Vig, P., Mandel, J., Fischbeck, K.H. and Pittman, R.N. (1997) Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron, 19, 333-344.
4. Seidel, K., Siswanto, S., Brunt, E.R.P., den Dunnen, W., Korf, H.-W. and Rüb, U. (2012) Brain pathology of spinocerebellar ataxias. Acta Neuropathol., 124, 1-21.
5. Seidel, K., Meister, M., Dugbartey, G.J., Zijlstra, M.P., Vinet, J., Brunt, E.R.P., van Leeuwen, F.W., Rüb, U., Kampinga, H.H. and den Dunnen, W.F.A. (2012) Cellular protein quality control and the evolution of aggregates in spinocerebellar ataxia type 3 (SCA3). Neuropathol. Appl. Neurobiol., 38, 548-558.
6. Saudou, F., Finkbeiner, S., Devys, D. and Greenberg, M.E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell, 95, 55-66.
7. Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R. and Finkbeiner, S. (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature, 431, 805-810.
8. Williams, A.J., Knutson, T.M., Colomer Gould, V.F. and Paulson, H.L. (2009) In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis. Neurobiol. Dis., 33, 342-353.
9. Labbadia, J., Novoselov, S.S., Bett, J.S.,Weiss, A., Paganetti, P., Bates, G.P. and Cheetham, M.E. (2012) Suppression of protein aggregation by chaperone modification of high molecular weight complexes. Brain, 135, 1180-1196.
10. Sontag, E.M., Lotz, G.P., Agrawal, N., Tran, A., Aron, R., Yang, G., Necula, M., Lau, A., Finkbeiner, S., Glabe, C. et al. (2012) Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models. J. Neurosci., 32, 11109-11119.
11. Hartl, F.U., Bracher, A. and Hayer-Hartl, M. (2011) Molecular chaperones in protein folding and proteostasis. Nature, 475, 324-332.
12. Malik, B., Nirmalananthan, N., Gray, A.L., La Spada, A.R., Hanna, M.G. and Greensmith, L. (2013) Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy. Brain, 136, 926-943.
13. Colomer Gould, V.F. (2012) Mouse models of spinocerebellar ataxia type 3 (Machado-Joseph disease). Neurotherapeutics, 9, 285-296.
14. Ishiguro, H., Yamada, K., Sawada, H., Nishii, K., Ichino, N., Sawada, M., Kurosawa, Y., Matsushita, N., Kobayashi, K., Goto, J. et al. (2001) Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene. J. Neurosci. Res., 65, 289-297.
15. Heng, M.Y., Duong, D.K., Albin, R.L., Tallaksen-Greene, S.J., Hunter, J.M., Lesort, M.J., Osmand, A., Paulson, H.L. and Detloff, P.J. (2010) Early autophagic response in a novel knock-in model of Huntington disease. Hum. Mol. Genet., 19, 3702-3720.
16. Yu, Z., Dadgar, N., Albertelli, M., Gruis, K., Jordan, C., Robins, D.M. and Lieberman, A.P. (2006) Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J. Clin. Invest., 116, 2663-2672.
17. Menalled, L.B., Sison, J.D., Dragatsis, I., Zeitlin, S. and Chesselet, M.-F. (2003) Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. J. Comp. Neurol., 465, 11-26.
18. Lorenzetti, D., Watase, K., Xu, B., Matzuk, M.M., Orr, H.T. and Zoghbi, H.Y. (2000) Repeat instability and motor incoordination in mice with a targeted expanded CAG repeat in the Sca1 locus. Hum. Mol. Genet., 9, 779-785.
19. Lam, Y.C., Bowman, A.B., Jafar-Nejad, P., Lim, J., Richman, R., Fryer, J.D., Hyun, E.D., Duvick, L.A., Orr, H.T., Botas, J. et al. (2006) ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell, 127, 1335-1347.
20. Watase, K., Barrett, C.F., Miyazaki, T., Ishiguro, T., Ishikawa, K., Hu, Y., Unno, T., Sun, Y., Kasai, S., Watanabe, M. et al. (2008) Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels. Proc. Natl Acad. Sci. USA., 105, 11987-11992.
21. Yoo, S.Y., Pennesi, M.E., Weeber, E.J., Xu, B., Atkinson, R., Chen, S., Armstrong, D.L., Wu, S.M., Sweatt, J.D. and Zoghbi, H.Y. (2003) SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity. Neuron, 37, 383-401.
22. Yang, S., Huang, S., Gaertig, M.A., Li, X.-J. and Li, S. (2014) Agedependent decrease in chaperone activity impairs MANF expression, leading to Purkinje cell degeneration in inducible SCA17 mice. Neuron, 81, 349-365.
23. Sathasivam, K., Neueder, A., Gipson, T.A., Landles, C., Benjamin, A.C., Housman, D.E. and Bates, G.P. (2012) Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc. Natl Acad. Sci. USA., 110, 2366-2370.
24. Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., Nakamura, S., Nishimura, M., Akiguchi, I. et al. (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet., 8, 221-228.
25. Maciel, P., Costa, M.C., Ferro, A., Rousseau, M., Santos, C.S., Gaspar, C., Barros, J., Rouleau, G.A., Coutinho, P. and Sequeiros, J. (2001) Improvement in the molecular diagnosis of Machado-Joseph disease. Arch. Neurol., 58, 1821-1827.
26. Watase, K., Venken, K.J.T., Sun, Y., Orr, H.T. and Zoghbi, H.Y. (2003) Regional differences of somatic CAG repeat instability do not account for selective neuronal vulnerability in a knock-in mouse model of SCA1. Hum. Mol. Genet., 12, 2789-2795.
27. Silva-Fernandes, A., Costa, M.D.C., Duarte-Silva, S., Oliveira, P., Botelho, C.M., Martins, L., Mariz, J.A., Ferreira, T., Ribeiro, F., Correia-Neves, M. et al. (2010) Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products. Neurobiol. Dis., 40, 163-176.
28. Goti, D., Katzen, S.M., Mez, J., Kurtis, N., Kiluk, J., Ben-Haïem, L., Jenkins, N.A., Copeland, N.G., Kakizuka, A., Sharp, A.H. et al. (2004) A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration. J. Neurosci., 24, 10266-10279.
29. Watase, K., Weeber, E.J., Xu, B., Antalffy, B., Yuva-Paylor, L., Hashimoto, K., Kano, M., Atkinson, R., Sun, Y., Armstrong, D.L. et al. (2002) A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron, 34, 905-919.
30. Wheeler, V.C., White, J.K., Gutekunst, C., Vrbanac, V.,Weaver, M., Li, X., Li, S., Yi, H., Vonsattel, J., Gusella, J.F. et al. (2000) Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in Hdh Q92 and Hdh Q111 knock-in mice. Hum. Mol. Genet., 9, 503-514.
31. Damrath, E., Heck, M.V., Gispert, S., Azizov, M., Nowock, J., Seifried, C., Rüb, U., Walter, M. and Auburger, G. (2012) ATXN2-CAG42 sequesters PABPC1 into insolubility and induces FBXW8 in cerebellum of old ataxic knock-in mice. PLoS Genet., 8, e1002920.
32. Menalled, L.B., Sison, J.D., Wu, Y., Olivieri, M., Li, X., Li, H. and Zeitlin, S. (2002) Early motor dysfunction and striosomal distribution of Huntingtin microaggregates in Huntington's disease knock-in mice. Hum. Mol. Genet., 22, 8266-8276.
33. Shelbourne, P.F., Killeen, N., Hevner, R.F., Johnston, H.M., Tecott, L., Lewandoski,M., Ennis,M., Ramirez, L., Li, Z., Iannicola, C. et al. (1999) Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum. Mol. Genet., 8, 763-774.
34. Mori, F.,Tanji,K.,Odagiri, S.,Toyoshima,Y., Yoshida,M.,Kakita, A., Takahashi, H. and Wakabayashi, K. (2012) Autophagyrelated proteins (p62, NBR1 and LC3) in intranuclear inclusions in neurodegenerative diseases. Neurosci. Lett., 522, 134-138.
35. Nascimento-Ferreira, I., Santos-Ferreira, T., Sousa-Ferreira, L., Auregan, G., Onofre, I., Alves, S., Dufour, N., Colomer Gould, V.F., Koeppen, A., Déglon, N. et al. (2011) Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease. Brain, 134, 1400-1415.
36. Hu, X., Shi, Q., Zhou, X., He,W., Yi, H., Yin, X., Gearing, M., Levey, A. and Yan, R. (2007) Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities. EMBO J., 26, 2755-2767.
37. Shi, Q., Hu, X., Prior, M. and Yan, R. (2009) The occurrence of aging-dependent reticulon 3 immunoreactive dystrophic neurites decreases cognitive function. J. Neurosci., 29, 5108-5115.
38. Maren, S. (2001) Neurobiology of Pavlovian fear conditioning. Annu. Rev. Neurosci., 24, 897-931.
39. Seredenina, T. and Luthi-Carter, R. (2012) What have we learned from gene expression profiles in Huntington's disease? Neurobiol. Dis., 45, 83-98.
40. Takahashi, T., Katada, S. and Onodera, O. (2010) Polyglutamine diseases: where does toxicity come from? What is toxicity? Where are we going? J. Mol. Cell Biol., 2, 180-191.
41. Schmidt, T., Landwehrmeyer, G.B., Schmitt, I., Trottier, Y., Auburger, G., Laccone, F., Klockgether, T., Völpel, M., Epplen, J.T., Schöls, L. et al. (1998) An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients. Brain Pathol., 8, 669-679.
42. Chai, Y., Koppenhafer, S.L., Shoesmith, S.J., Perez, M.K. and Paulson, H.L. (1999) Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet., 8, 673-682.
43. Chai, Y., Wu, L., Griffin, J.D. and Paulson, H.L. (2001) The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease. J. Biol. Chem., 276, 44889-44897.
44. Goto, J.,Watanabe, M., Ichikawa, Y., Yee, S.B., Ihara, N., Endo, K., Igarashi, S., Takiyama, Y., Gaspar, C., Maciel, P. et al. (1997) Machado-Joseph disease gene products carrying different carboxyl termini. Neurosci. Res., 28, 373-377.
45. Harris, G.M., Dodelzon, K., Gong, L., Gonzalez-Alegre, P. and Paulson, H.L. (2010) Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties. PLoS ONE, 5, e13695.
46. Robinson, J.T., Thorvaldsdottir, H.,Winckler,W., Guttman, M., Lander, E., Getz, G. and Mesirov, J.P. (2011) Integrative genomics viewer. Nat. Biotechnol., 29, 24-26.
47. Thorvaldsdóttir, H., Robinson, J.T. and Mesirov, J.P. (2013) Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinform., 14, 178-192.
48. Cemal, C.K., Carroll, C.J., Lawrence, L., Lowrie, M.B., Ruddle, P., Al-Mahdawi, S., King, R.H.M., Pook, M.A., Huxley, C. and Chamberlain, S. (2002) YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit. Hum. Mol. Genet., 11, 1075-1094.
49. Rüb, U., Schöls, L., Paulson, H., Auburger, G., Kermer, P., Jen, J.C., Seidel, K., Korf, H.-W. and Deller, T. (2013) Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog. Neurobiol., 104, 38-66.
50. Klement, I.A., Skinner, P.J., Kaytor, M.D., Yi, H., Hersch, S.M., Clark, H.B., Zoghbi, H.Y. and Orr, H.T. (1998) Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice. Cell, 95, 41-53.
51. Bichelmeier, U., Schmidt, T., Hübener, J., Boy, J., Rüttiger, L., Häbig, K., Poths, S., Bonin, M., Knipper, M., Schmidt, W.J. et al. (2007) Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. J. Neurosci., 27, 7418-7428.
52. Peters, M.F., Nucifora, F.C.N. Jr, Kushi, J., Seaman, H.C., Cooper, J.K., Herring, W.J., Dawson, V.L., Dawson, T.M. and Ross, C.A. (1999) Nuclear targeting of mutant Huntingtin increased toxicity. Mol. Cell. Neurosci., 14, 121-128.
53. Koch, P., Breuer, P., Peitz, M., Jungverdorben, J., Kesavan, J., Poppe, D., Doerr, J., Ladewig, J., Mertens, J., Tüting, T. et al. (2011) Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease. Nature, 480, 543-546.
54. Feng, L., Chen, D.B., Hou, L., Huang, L.H., Lu, S.Y., Liang, X.L. and Li, X.H. (2014) Cognitive impairment in native Chinese with spinocerebellar ataxia type 3. Eur. Neurol., 71, 262-270.
55. Lopes, T.M., D'Abreu, A., França, M.C., Yasuda, C.L., Betting, L.E., Samara, A.B., Castellano, G., Somazz, J.C., Balthazar, M.L.F., Lopes-Cendes, I. et al. (2013) Widespread neuronal damage and cognitive dysfunction in spinocerebellar ataxia type 3. J. Neurol., 260, 2370-2379.
56. Roeske, S., Filla, I., Heim, S., Amunts, K., Helmstaedter, C., Wüllner, U., Wagner, M., Klockgether, T. and Minnerop, M. (2013) Progressive cognitive dysfunction in spinocerebellar ataxia type 3. Mov. Disord., 28, 1435-1438.
57. Seidel, K., den Dunnen,W.F.A., Schultz, C., Paulson, H., Frank, S., de Vos, R.A., Brunt, E.R., Deller, T., Kampinga, H.H. and Rüb, U. (2010) Axonal inclusions in spinocerebellar ataxia type 3. Acta Neuropathol., 120, 449-460.
58. Lin, C., Tallaksen-Greene, S., Chien,W., Cearley, J.A., Jackson, W.S., Crouse, A.B., Ren, S., Li, X., Albin, R.L. and Detloff, P.J. (2001) Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum. Mol. Genet., 10, 137-144.
59. Gipson, T.A., Neueder, A., Wexler, N.S., Bates, G.P. and Housman, D.E. (2013) Aberrantly spliced HTT, a newplayer in Huntington's disease pathogenesis. RNA Biol., 10, 1-6.
60. Pinto, P.A.B., Henriques, T., Freitas, M.O., Martins, T., Domingues, R.G., Wyrzykowska, P.S., Coelho, P.A., Carmo, A.M., Sunkel, C.E., Proudfoot, N.J. et al. (2011) RNA polymerase II kinetics in polo polyadenylation signal selection. EMBO J., 30, 2431-2444.
61. De Mata, M., Alonso, C.R., Fededa, J.P., Pelisch, F., Cramer, P., Bentley, D. and Kornblihtt, A.R. (2003) A slow RNA polymerase II affects alternative splicing in vivo. Mol. Cell, 12, 525-532.
62. Elkon, R., Ugalde, A.P. and Agami, R. (2013) Alternative cleavage and polyadenylation: extent, regulation and function. Nat. Rev. Genet., 14, 496-506.
63. Geiser, M., Cebe, R., Drewello, D. and Schmitz, R. (2001) Integration of PCR fragments at any specific site within cloning vectors without the use of restriction enzymes and DNA ligase. Biotechniques, 31, 88-90.
64. Laccone, F., Maiwald, R. and Bingemann, S. (1999) A fast polymerase chain reaction-mediated strategy for introducing repeat expansions into CAG-repeat containing genes. Hum. Mutat., 13, 497-502.
65. Hughes, E.D., Qu, Y.Y., Genik, S.J., Lyons, R.H., Pacheco, C.D., Lieberman, A.P., Samuelson, L.C., Nasonkin, I.O., Camper, S. A., Van Keuren, M.L. et al. (2007) Genetic variation in C57BL/ 6 ES cell lines and genetic instability in the Bruce4 C57BL/6 ES cell line. Mamm. Genome, 18, 549-558.
66. Paulson, H.L., Das, S.S., Crino, P.B., Perez, M.K., Patel, S.C., Gotsdiner, D., Fischbeck, K.H. and Pittman, R.N. (1997) Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann. Neurol., 41, 453-462.
67. Heng, M.Y., Tallaksen-Greene, S.J., Detloff, P.J. and Albin, R.L. (2007) Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's disease. J. Neurosci., 27, 8989-8998.
68. Perkowski, J.J. and Murphy, G.G. (2011) Deletion of the mouse homolog of KCNAB2, a gene linked to monosomy 1p36, results in associative memory impairments and amygdala hyperexcitability. J. Neurosci., 31, 46-54.
69. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.